Delivery Order SPE2DB22D2006-SPE2DB25FV5VX

Award Date 10/24/24
Potential Completion Date 10/25/24
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,526.58 delivery order is for the supply of Neupogen 480 mcg/0.8 ml syringes. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of NEUPOGEN 480 MCG/1.6 ML vials. The $19,851.00 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award, valued at $1,214.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the procurement of NEUPOGEN 300 MCG/ML VIALML, a medical product, with a firm fixed price and an ultimate completion date of March 28, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,258.62, is a delivery order for NEUPOGEN 300 MCG/0.5 ML SYR 0.5ML, a specialty medication. There was no set-aside designation, indicating this was a full and open competition. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,739.66 firm-fixed-price delivery order is for the supply of NEUPOGEN 480 MCG/0.8 ML SYR 0.8ML, a specialty medication. The award is not associated with a set-aside program and has an ultimate completion date of November 10, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,695.17 firm-fixed-price delivery order is for NEULASTA ONPRO 6 MG/0.6 ML KIT 0.6ML, a specialty medication, to support military healthcare programs. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $6,187.58 for the supply of Neulasta OnPro 6 mg/0.6 ml kits. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, for providing a comprehensive range of medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,035.48 firm fixed price delivery order is for the supply of NEULASTA 6 MG/0.6 ML SYRINGE 0.6ML, a specialty medication, with a performance period through April 2025. The contract is not designated with a set-aside and represents open competition. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery...
This federal contract award is for the supply of Neulasta OnPro pharmaceutical kits to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is a firm fixed price delivery order valued at $9,183.96, with a completion date of February 6, 2024. Amerisourcebergen Drug Corp has received numerous similar awards from DLA Troop Support Medical to...
The federal contract award is for the delivery of Gonal-F RFF Redi-Ject 300 unit 0.5ml pharmaceutical products to the Defense Logistics Agency (DLA). The $1,018.38 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor. The contract does not have any set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FV5VX
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $2,465.01 firm-fixed-price delivery order is for the supply of Neupogen 300 mcg/mL vials, a medication used to treat certain types of cancer and other medical conditions.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. AmerisourceBergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 1/23/25, 9:38 AM